Drug Profile
PNU 142769
Latest Information Update: 14 Dec 2000
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 14 Dec 2000 No-Development-Reported for Undefined in USA (Unknown route)
- 06 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation
- 22 Sep 1998 Preclinical development for Undefined in USA (Unknown route)